Skip to main content
SpringerLink
Log in

Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Caocci G, Mulas O, Capodanno I, Bonifacio M, Annunziata M, Galimberti S, Luciano L, Tiribelli M, Martino B, Castagnetti F, Binotto G, Pregno P, Stagno F, Abruzzese E, Bocchia M, Gozzini A, Albano F, Fozza C, Luzi D, Efficace F, Simula MP, Scaffidi L, Baratè C, De Gregorio F, Stella R, Gugliotta G, Pirillo F, Trawinska MM, Sicuranza A, Cattaneo D, Attolico I, Scalzulli E, Iurlo A, Foà R, Breccia M, La Nasa G (2021) Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib. Ann Hematol.

  2. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESC Scientific Document Group (2020) 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111–188

    Article  Google Scholar 

  3. Barbui T, Tefferi A, Vannucchi AM, Passamonti F, Silver RT, Hoffman R, Verstovsek S, Mesa R, Kiladjian JJ, Hehlmann R, Reiter A, Cervantes F, Harrison C, Mc Mullin MF, Hasselbalch HC, Koschmieder S, Marchetti M, Bacigalupo A, Finazzi G, Kroeger N, Griesshammer M, Birgegard G, Barosi G (2018) Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. Leukemia 32(5):1057–1069

    Article  Google Scholar 

  4. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405

    Article  CAS  Google Scholar 

  5. Griner LN, McGraw KL, Johnson JO, List AF, Reuther GW (2016) JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth. Br J Haematol 160(2):177–187

    Article  Google Scholar 

  6. Krečak I, Holik H, Morić-Perić M, Zekanović I, Coha B, Gverić-Krečak V (2020) The impact of statins on the intensity of phlebotomies in polycythemia vera. Ann Hematol 99(4):911–912

    Article  Google Scholar 

  7. Hasselbalch HC, Riley CH (2006) Statins in the treatment of polycythaemia vera and allied disorders: an antithrombotic and cytoreductive potential? Leuk Res 30(10):1217–1225

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, General Hospital of Šibenik-Knin County, Stjepana Radića 83, 22000, Šibenik, Croatia

    Ivan Krečak & Velka Gverić-Krečak

  2. Department of Internal Medicine, “Dr. Josip Benčević“ General Hospital, Slavonski Brod, Croatia

    Hrvoje Holik & Božena Coha

  3. Department of Internal Medicine, General Hospital Zadar, Zadar, Croatia

    Martina Morić Perić & Ivan Zekanović

  4. Department of Psychiatry, General Hospital of Šibenik-Knin County, Šibenik, Croatia

    Marija Valovičić Krečak

  5. University Hospital Dubrava, Zagreb, Croatia

    Marko Lucijanić

  6. School of Medicine, University of Zagreb, Zagreb, Croatia

    Marko Lucijanić

Authors
  1. Ivan Krečak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hrvoje Holik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Božena Coha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martina Morić Perić
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ivan Zekanović
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marija Valovičić Krečak
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Velka Gverić-Krečak
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marko Lucijanić
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ivan Krečak.

Ethics declarations

Ethics approval and consent to participate

The study was performed in accordance with Declaration of Helsinki and was approved by the Ethics Committees from all participating centers; General Hospital of Šibenik-Knin County (reference number 01-3618/1-20), General Hospital Zadar (reference number 02-2025/20-6/20), and “Dr. Josip Benčević“ General Hospital (reference number 04000000/20-37). Due to the retrospective design of the study, informed consent was not obtained.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krečak, I., Holik, H., Coha, B. et al. Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera. Ann Hematol 100, 1335–1336 (2021). https://doi.org/10.1007/s00277-021-04431-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-021-04431-0

Search

Navigation